Diagnostic testing company LumiraDx and CA Healthcare Acquisition completed their merger. LumiraDx shares begin trading today on the Nasdaq under LMDX. Warrants list under LMDXW. The company listed at a valuation of $3 billion. Read more.
LumiraDX Closes SPAC Merger, Begins Trading on Nasdaq
